Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | PYGB | P11216 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3294754 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL5706329 | 1.00 | LGALS1 (0.45) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL6435260 | 0.82 | LMNA (0.38) | — | |
| SCHEMBL25292780 | 0.81 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL2490550 | 0.81 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| SCHEMBL2493091 | 0.81 | LGALS1 (0.40) | LGALS1LGALS3LGALS9LGALS8PPARG | |
| B-D-Galactose SCHEMBL27599841 | 0.81 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| B-D-Galactose SCHEMBL8994742 | 0.81 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| D-Galactose SCHEMBL28145478 | 0.81 | LGALS1 (0.47) | LGALS1LGALS3LGALS9LGALS8L3MBTL1 | |
| SCHEMBL25291631 | 0.80 | LGALS1 (0.39) | LGALS1LGALS3LGALS9LGALS8PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853169-B2 | C-glycosides, uses thereof | L'OREAL (FR) | 2014-10-07 | — | — | US | disclosed |
| US-20080146516-A1 | Cosmetic glycosaminoglycan synthesis stimulators; treating keratin materials; combating skin aging and/or drying out | L 'OREAL SA (FR) | 2008-06-19 | — | — | US | disclosed |
| EP-1589010-B1 | New C-Glycoside derivatives and uses thereof | OREAL (FR) | 2008-06-11 | — | — | EP | disclosed |
| US-7358346-B2 | Synthesis of C-beta-D-xylopyranoside-2-(S)-hydroxypropane or C-beta-D-fucopyranoside-2-(S)-hydroxypropane from C-beta-D-xylopyranoside-2-propanone or c-beta-D-fucopyranoside-2-propanone using sodium borohydride, isopropanol and sodium triacetoxyborohydride; glycosaminoglycans | L'OREAL (FR) | 2008-04-15 | — | — | US | disclosed |
| US-20050250708-A1 | Synthesis of C-beta-D-xylopyranoside-2-(S)-hydroxypropane or C-beta-D-fucopyranoside-2-(S)-hydroxypropane from C-beta-D-xylopyranoside-2-propanone or c-beta-D-fucopyranoside-2-propanone using sodium borohydride, isopropanol and sodium triacetoxyborohydride; glycosaminoglycans | L'OREAL (FR) | 2005-11-10 | — | — | US | disclosed |
| EP-1589010-A1 | New C-Glycoside derivatives and uses thereof | L'OREAL (FR) | 2005-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250708-A1 | Synthesis of C-beta-D-xylopyranoside-2-(S)-hydroxypropane or C-beta-D-fucopyranoside-2-(S)-hydroxypropane from C-beta-D-xylopyranoside-2-propanone or c-beta-D-fucopyranoside-2-propanone using sodium borohydride, isopropanol and sodium triacetoxyborohydride; glycosaminoglycans | HEXD, FUCA1, FUT6 | LGALS1 152/4885LGALS3 107/4885LGALS9 763/4885 |
| US-20080146516-A1 | Cosmetic glycosaminoglycan synthesis stimulators; treating keratin materials; combating skin aging and/or drying out | GLA, FUT5, FUT6 | LGALS1 55/4885LGALS3 68/4885LGALS9 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.